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spacing of 7.1 mm center to center. During measurements, 
the 2D-arrays are embedded in the Octavius 4D phantom. 
The software used with Octavius 4D to compare the TPS 
calculated treatments and the measured treatments in the 
accelerator, was the Verisoft 6.0. Octavius 4D measures 
planar dose distributions depending on the gantry angle and 
after that, the software reconstructs a 3D dose distribution. 
To obtain the differences between dose distributions, 
calculated with the TPS vs measured on the accelerator, the 
local 3D gamma-index (3%, 3 mm criterion) with a threshold 
of 10% for the maximum absorbed dose was used. 
Results: The global results were: 99.97±0.10% of evaluated 
voxels passed the gamma-index criterion for Octavius 1000 
SRS; 99.44 ±0.39 % for Octavius 1500; and 95.37±1.33 % for 
Octavius 729. There is a clear relationship between the 
resolution of the 2D-array and the number of points passing 
the 3D gamma-index criterion. 
Table I shows the results obtained by comparing the 
measured modified plans and the original plan given by the 
TPS. Here we could see that as the chamber sizes is less, the 
detector is more sensitive to detect the forced variation in 
the leaves position due to the signal averaging is lower. 
 
Conclusions: Octavius 1000 SRS is the most suitable to verify 
SBRT. It gives the best results for the 3D gamma-index 
criterion due to it has the smallest distance between 
chambers and it’s the most sensitive detecting the errors or 
position variations in the leaves due to the smallest size of its 
chambers. Octavius 1500 is also useful to verify SBRT and 
allows to measure IMRT treatments due to its size.  
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Purpose/Objective: To examine the UK’s current practices in 
CSRS. 
Materials and Methods: A questionnaire, designed to include 
Gamma Knife (GK), Cyberknife (CK), Linac-Based (LB) and 
TomoTherapy (TT), was sent to 70 radiotherapy and 
radiosurgery centres in the UK between June and November 
2014.  
Results: 85.7% (60/70) of centres responded. Of these, 33.3% 
(20/60) were performing CSRS, 8.3% (5/60) are in the process 
of implementing CSRS and are planning to be clinical by 
August 2015 and 8.3% (5/60) are planning to implement CSRS 
by October 2016. The remaining 50% (30/60) are not 
performing CSRS and do not plan to implement it before 
October 2016. 
25% (5/20) treat up to 4 patients per month, 45% (9/20) treat 
5-15 patients per month and 30% (6/20) treat more than 16 
patients per month. There are 29 machines used for CSRS in 
the country (14 LB, 6 CK, 7 GK and 1 TT) but they are not all 
dedicated to CSRS. The most commonly used techniques are 
non-coplanar static fields (used by 85% of centres), non-
coplanar dynamic conformal arcs (20%) and circular 
collimator arcs (20%). 70% are using 6MV photons and 30% 
using Cobalt-60 (~1.25MV). A range of imaging modalities is 
used for outlining: Fused CT&MR (70%), MR (60%), CT (50%), 
Angiogram (45%), PET (20%) and Fused CT&PET (10%).  
A large range of answers were given for the most common 
prescription isodose. Two peaks were seen: 20% (4/20) 
usually prescribe to the 45-50% isodose, 20% (4/20) to the 80-
85% isodose, with the remaining centres prescribing between 
these 2 groups and up to the 95-100% isodose.  
Patient specific QA measurements are performed on every 
plan by 35% (7/20) and 65% (13/20) decreased the 
measurements taken after 10-25 plans. The results show a 
wide range of detectors and phantoms being used for QA 
measurements.  
The most common treatment sites are solitary and multiple 
brain metastases, followed by acoustic neuromas, 
meningiomas and AVMs. The majority of centres (70%) stated 
that treatment delivery usually takes less than 1 hour. 
The results show that pre-treatment and during-treatment 
imaging is used in the majority of CK and LB treatments but 
not used at all in GK. When asked for a figure of acceptable 
setup accuracy, 50% stated sub-millimetre accuracies with 
the remaining ranging from 1-2mm. 
Conclusions: The number of centres delivering CSRS is 
increasing and will continue to increase in the next 2-3 years. 
This is particularly the case with LB radiosurgery. Most 
centres are aiming to expand their service to treat more 
indications and more patients. There is a wide variety of 
planning procedures, QA methods, prescription protocols and 
delivery practices despite the fact that the indications 
treated by all centres are comparable.  
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Purpose/Objective: To compare the daily dose measurement 
of Flattening Filter (FF) beams with Flattening Filter Free 
(FFF) beams of 6MV and 10MV in Elekta Versa HD, and to 
evaluate the performance of using daily constancy check 
device with lowered dose rate in FFF beams. 
Materials and Methods: The daily assurance measurement, 
including Central Axis Dose (CAX), beam flatness, beam 
symmetry (GT and LR direction), and beam quality factor 
